BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 29953259)

  • 1. Delineating the Cellular Mechanisms Associated with Skin Electroporation.
    Schultheis K; Smith TRF; Kiosses WB; Kraynyak KA; Wong A; Oh J; Broderick KE
    Hum Gene Ther Methods; 2018 Aug; 29(4):177-188. PubMed ID: 29953259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin Transfection Patterns and Expression Kinetics of Electroporation-Enhanced Plasmid Delivery Using the CELLECTRA-3P, a Portable Next-Generation Dermal Electroporation Device.
    Amante DH; Smith TR; Mendoza JM; Schultheis K; McCoy JR; Khan AS; Sardesai NY; Broderick KE
    Hum Gene Ther Methods; 2015 Aug; 26(4):134-46. PubMed ID: 26222896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel prototype device for electroporation-enhanced DNA vaccine delivery simultaneously to both skin and muscle.
    Lin F; Shen X; McCoy JR; Mendoza JM; Yan J; Kemmerrer SV; Khan AS; Weiner DB; Broderick KE; Sardesai NY
    Vaccine; 2011 Sep; 29(39):6771-80. PubMed ID: 21199706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of electroporation-enhanced intradermal delivery of DNA vaccine using a minimally invasive surface device.
    Lin F; Shen X; Kichaev G; Mendoza JM; Yang M; Armendi P; Yan J; Kobinger GP; Bello A; Khan AS; Broderick KE; Sardesai NY
    Hum Gene Ther Methods; 2012 Jun; 23(3):157-68. PubMed ID: 22794496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electroporation mediated DNA vaccination directly to a mucosal surface results in improved immune responses.
    Kichaev G; Mendoza JM; Amante D; Smith TR; McCoy JR; Sardesai NY; Broderick KE
    Hum Vaccin Immunother; 2013 Oct; 9(10):2041-8. PubMed ID: 23954979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adipose tissue: a new target for electroporation-enhanced DNA vaccines.
    Fisher PD; Brambila CJ; McCoy JR; Kiosses WB; Mendoza JM; Oh J; Yung BS; Schultheis K; Smith TRF; Broderick KE
    Gene Ther; 2017 Dec; 24(12):757-767. PubMed ID: 29106403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electroporation of a nanoparticle-associated DNA vaccine induces higher inflammation and immunity compared to its delivery with microneedle patches in pigs.
    Bernelin-Cottet C; Urien C; McCaffrey J; Collins D; Donadei A; McDaid D; Jakob V; Barnier-Quer C; Collin N; Bouguyon E; Bordet E; Barc C; Boulesteix O; Leplat JJ; Blanc F; Contreras V; Bertho N; Moore AC; Schwartz-Cornil I
    J Control Release; 2019 Aug; 308():14-28. PubMed ID: 31265882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prototype development and preclinical immunogenicity analysis of a novel minimally invasive electroporation device.
    Broderick KE; Shen X; Soderholm J; Lin F; McCoy J; Khan AS; Yan J; Morrow MP; Patel A; Kobinger GP; Kemmerrer S; Weiner DB; Sardesai NY
    Gene Ther; 2011 Mar; 18(3):258-65. PubMed ID: 20962869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multi-head intradermal electroporation device allows for tailored and increased dose DNA vaccine delivery to the skin.
    McCoy JR; Mendoza JM; Spik KW; Badger C; Gomez AF; Schmaljohn CS; Sardesai NY; Broderick KE
    Hum Vaccin Immunother; 2014; 10(10):3039-47. PubMed ID: 25483486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerability of intramuscular and intradermal delivery by CELLECTRA(®) adaptive constant current electroporation device in healthy volunteers.
    Diehl MC; Lee JC; Daniels SE; Tebas P; Khan AS; Giffear M; Sardesai NY; Bagarazzi ML
    Hum Vaccin Immunother; 2013 Oct; 9(10):2246-52. PubMed ID: 24051434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of guinea pig T cell responses elicited after EP-assisted delivery of DNA vaccines to the skin.
    Schultheis K; Schaefer H; Yung BS; Oh J; Muthumani K; Humeau L; Broderick KE; Smith TR
    Vaccine; 2017 Jan; 35(1):61-70. PubMed ID: 27894716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multi-head intradermal electroporation device allows for tailored and increased dose DNA vaccine delivery to the skin.
    McCoy JR; Mendoza JM; Spik KW; Badger C; Gomez AF; Schmaljohn CS; Sardesai NY; Broderick KE
    Hum Vaccin Immunother; 2015; 11(3):746-54. PubMed ID: 25839221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA vaccination in skin enhanced by electroporation.
    Broderick KE; Khan AS; Sardesai NY
    Methods Mol Biol; 2014; 1143():123-30. PubMed ID: 24715285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct transfection of dendritic cells in the epidermis after plasmid delivery enhanced by surface electroporation.
    Amante DH; Smith TR; Kiosses BB; Sardesai NY; Humeau LM; Broderick KE
    Hum Gene Ther Methods; 2014 Dec; 25(6):315-6. PubMed ID: 25470335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electroporation as a vaccine delivery system and a natural adjuvant to intradermal administration of plasmid DNA in macaques.
    Todorova B; Adam L; Culina S; Boisgard R; Martinon F; Cosma A; Ustav M; Kortulewski T; Le Grand R; Chapon C
    Sci Rep; 2017 Jun; 7(1):4122. PubMed ID: 28646234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delivery of DNA into skin via electroporation.
    Medi BM; Singh J
    Methods Mol Biol; 2008; 423():225-32. PubMed ID: 18370202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influenza A vaccines using linear expression cassettes delivered via electroporation afford full protection against challenge in a mouse model.
    Shen X; Söderholm J; Lin F; Kobinger G; Bello A; Gregg DA; Broderick KE; Sardesai NY
    Vaccine; 2012 Nov; 30(48):6946-54. PubMed ID: 22406460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin targeted DNA vaccine delivery using electroporation in rabbits. I: efficacy.
    Medi BM; Hoselton S; Marepalli RB; Singh J
    Int J Pharm; 2005 Apr; 294(1-2):53-63. PubMed ID: 15814230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electroporation-enhanced delivery of nucleic acid vaccines.
    Broderick KE; Humeau LM
    Expert Rev Vaccines; 2015 Feb; 14(2):195-204. PubMed ID: 25487734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-DNA Given with or without Intradermal Electroporation Is Safe and Highly Immunogenic in Healthy Swedish HIV-1 DNA/MVA Vaccinees: A Phase I Randomized Trial.
    Nilsson C; Hejdeman B; Godoy-Ramirez K; Tecleab T; Scarlatti G; Bråve A; Earl PL; Stout RR; Robb ML; Shattock RJ; Biberfeld G; Sandström E; Wahren B
    PLoS One; 2015; 10(6):e0131748. PubMed ID: 26121679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.